←Back to Expert Scholars
Translational Medicine / 转化医学Lung Oncogenic Fusions
Rafael Rosell
MD, PhD
🏢Catalan Institute of Oncology🌐Spain
Scientific Director, Catalan Institute of Oncology
115
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Rafael Rosell led landmark EGFR NSCLC trials including EURTAC establishing erlotinib first-line therapy. His work has shaped European lung cancer biomarker testing practices. He continues to investigate fusion oncogene and resistance biology.
Share:
🧪Research Fields 研究领域
EGFR NSCLC
ALK biology
Translational research
European cooperative trials
Liquid biopsy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Rafael Rosell 的研究动态
Follow Rafael Rosell's research updates
留下邮箱，当我们发布与 Rafael Rosell（Catalan Institute of Oncology）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment